Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Senseonics Holdings, Inc. (SENS : NSDQ)

• Company Description    Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States. Number of Employees: 130

• Price / Volume Information    Yesterday's Closing Price: $6.34 Daily Weekly Monthly 20 Day Moving Average: 1,349,566 shares Shares Outstanding: 41.80 (millions) Market Capitalization: $265.03 (millions) Beta: 1.05 52 Week High: $12.58 52 Week Low: $4.79 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -9.43% -13.85% 12 Week -24.07% -29.81% Year To Date 14.85% 2.60%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 20451 Seneca Meadows Parkway - Germantown,MD 20876 USA ph: 301-515-7260 fax: 301-515-0988 investors@senseonics.com http://www.senseonics.com

• General Corporate Information    Officers Timothy T. Goodnow - President; Chief Executive Officer and Director Stephen P. DeFalco - Chairman Rick Sullivan - Chief Financial Officer Steven Edelman - Director Edward J. Fiorentino - Director Peer Information Senseonics Holdings, Inc. (HLIS) Senseonics Holdings, Inc. (AZTA) Senseonics Holdings, Inc. (APYI) Senseonics Holdings, Inc. (RNVA) Senseonics Holdings, Inc. (HMSY) Senseonics Holdings, Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 81727U303 SIC: 3823 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/05/26 Share - Related Items Shares Outstanding: 41.80 Most Recent Split Date: 10.00 (0.05:1) Beta: 1.05 Market Capitalization: $265.03 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.55 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.38 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/05/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 7.72 Price/Cash Flow: - Price / Sales: 6.50 EPS Growth vs. Year Ago Period: -77.50% vs. Previous Quarter: -54.35% Sales Growth vs. Year Ago Period: 87.17% vs. Previous Quarter: -18.10% ROE 03/31/26 - -129.97 12/31/25 - -102.69 09/30/25 - -133.22 ROA 03/31/26 - -67.14 12/31/25 - -54.87 09/30/25 - -53.40 Current Ratio 03/31/26 - 3.51 12/31/25 - 4.83 09/30/25 - 6.23 Quick Ratio 03/31/26 - 3.19 12/31/25 - 4.55 09/30/25 - 5.93 Operating Margin 03/31/26 - -213.87 12/31/25 - -195.72 09/30/25 - -217.71 Net Margin 03/31/26 - -213.87 12/31/25 - -195.72 09/30/25 - -217.71 Pre-Tax Margin 03/31/26 - -213.93 12/31/25 - -196.03 09/30/25 - -217.62 Book Value 03/31/26 - 0.82 12/31/25 - 1.49 09/30/25 - 1.92 Inventory Turnover 03/31/26 - 3.00 12/31/25 - 3.50 09/30/25 - 3.46 Debt-to-Equity 03/31/26 - 1.05 12/31/25 - 0.58 09/30/25 - 0.45 Debt-to-Capital 03/31/26 - 51.12 12/31/25 - 36.83 09/30/25 - 31.09

Powered by Zacks Investment Research ©